← Back to Clinical Trials
Recruiting NCT06717048

NCT06717048 Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06717048
Status Recruiting
Phase
Sponsor Shanghai Eye Disease Prevention and Treatment Center
Condition Myopia
Study Type INTERVENTIONAL
Enrollment 108 participants
Start Date 2024-12-09
Primary Completion 2025-04-09

Trial Parameters

Condition Myopia
Sponsor Shanghai Eye Disease Prevention and Treatment Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 108
Sex ALL
Min Age 8 Years
Max Age 10 Years
Start Date 2024-12-09
Completion 2025-04-09
Interventions
Repeated Low-level Red-lightRed LED

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.

Eligibility Criteria

Inclusion Criteria: 1. Age: 8-10 years old 2. Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye. 3. signed informed consent and was able to participate in the study Exclusion Criteria: 1. Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome 2. Strabismus or other binocular vision abnormalities 3. Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery 4. Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc. 5. History of refractive surgery, internal eye surgery, laser therapy, vitreous injection, etc. 6. diabetes, hypertension and other systemic disorders 7. Hist

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology